Trial intelligence / Profile preview

Carbetocin vs Oxytocin and Misoprostol for Prevention of Postpartum Hemorrhage in Severe Preeclampsia

NCT04756661Completed

Sponsor
Assiut University
Start
Jan 2020
Primary completion
Dec 2020
Modality
Peptides
Countries
1
01

Overview

Trial of carbetocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Assiut University. Primary endpoint: Rate of postpartum hemorrhage more than 1000 ml at 30 minutes. Started Jan 2020; status: completed.

02

Drugs

carbetocin
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT04756661.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04756661.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call